Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sembiosys Genetics Inc. SBIYF

Healthcare Biotechnology
"SemBioSys Genetics Inc is engaged in developing high-value proteins and oils in plant seeds using its unique proprietary genetic expression and manufacturing technology platforms. The Company has operations in United States and Canada."


GREY:SBIYF - Post by User

Sembiosys Genetics Inc. > Tasly Won
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Comment by jerrio78on Apr 05, 2012 10:47am
172 Views
Post# 19762793

RE: Tasly Won

RE: Tasly Won

I found even the original news suspect. They were one of so many other companies they inked a deal with. This didn't mean instant wealth for the company and the increase in market cap showed me a lot of investors rushed in without waiting to see the numbers crunched.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities